|
Volumn 31, Issue 8, 2002, Pages 496-504
|
The role of attention-deficit/hyperactivity disorder diagnostic and treatment guidelines in changing physician practices
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CENTRAL STIMULANT AGENT;
DEXAMPHETAMINE;
METHYLPHENIDATE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
EVIDENCE BASED MEDICINE;
HUMAN;
PRACTICE GUIDELINE;
REVIEW;
SCHOOL CHILD;
ARTICLE;
CHILD;
PEDIATRICS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
BEHAVIOR THERAPY;
CHILD;
EVIDENCE-BASED MEDICINE;
HUMANS;
PEDIATRICS;
PRACTICE GUIDELINES;
|
EID: 0036022202
PISSN: 00904481
EISSN: None
Source Type: Journal
DOI: 10.3928/0090-4481-20020801-09 Document Type: Review |
Times cited : (6)
|
References (14)
|